Cystic fibrosis: an overview.

Area of Science:

• Genetics
• Molecular Biology
• Medical Science

Background:

• Cystic fibrosis (CF) is a prevalent inherited disorder in Caucasian populations.
• The identification of the cystic fibrosis transmembrane conductance regulator (CFTR) gene has enhanced comprehension of CF pathophysiology and diagnosis.
• Despite advancements, the complexity of CF and challenges in gene replacement therapy persist.

Purpose of the Study:

• To summarize recent progress in understanding the genetic basis of cystic fibrosis.
• To review current and emerging treatment strategies for cystic fibrosis.
• To highlight the complexity of CF and the ongoing challenges in therapeutic development.

Main Methods:

• Review of scientific literature on cystic fibrosis genetics and treatment.
• Analysis of the impact of CFTR gene discovery on CF research.
• Evaluation of advancements in symptomatic treatment and gene therapy approaches.

Main Results:

• The discovery of the CFTR gene has significantly improved understanding of CF.
• Gene replacement therapy faces challenges in cell targeting.
• Improved symptomatic treatments have led to increased life expectancy for CF patients.

Conclusions:

• Continued research into CFTR gene function is crucial.
• Overcoming delivery challenges is key for effective gene therapy.
• Multifaceted treatment strategies have improved outcomes for individuals with cystic fibrosis.